期刊文献+

hTERT反义寡聚核苷酸对子宫内膜癌细胞Bcl-2蛋白含量的影响 被引量:1

Effects of h TERT antisense oligodeoxynucleotide on the expression levels of Bcl-2 protein in endometrial carcinoma cells
下载PDF
导出
摘要 目的观察人端粒酶逆转录酶反义寡聚脱氧核苷酸对子宫内膜癌Ishikawa细胞株Bcl-2蛋白表达含量的影响。方法将2.5μmol/L、5μmol/L及10μmol/L人端粒酶逆转录酶反义寡聚脱氧核苷酸与Ishikawa细胞株共同培养,于24、48、72 h采用MTT法检测细胞增殖,于48 h使用流式细胞仪检测细胞凋亡和Bcl-2蛋白表达。结果人端粒酶逆转录酶反义寡聚脱氧核苷酸呈时间和剂量依赖性抑制Ishikawa细胞增殖,并可呈剂量依赖性诱导Ishikawa细胞凋亡、降低Bcl-2蛋白表达量。结论人端粒酶逆转录酶反义寡聚脱氧核苷酸可以诱导Ishikawa细胞凋亡、抑制肿瘤细胞增殖,该作用与降低Bcl-2蛋白表达量有关。 Objective To investigate the effects of h TERT antisense oligodeoxynucleotide( ASODN) on the expression levels of Bcl-2 protein in human endometrial carcinoma Ishikawa cells. Methods Human endometrial carcinoma Ishikawa cells were cultured in the medium with 2. 5,5 and10 umol / L h TERT ASODN for 24 h,48h,72 h,then the cell proliferation of Ishikawa cells was detected by MTT assay. The apoptosis rate of Ishikawa cells and the expression levels of Bcl-2 protein were detected by flow cytometry on 48 h. Results The h TERT ASODN inhibited proliferation of Ishikawa cells in a dose-dependent and time-dependent manner,moreover,which could induce apoptosis of Ishikawa cells in a dose-dependent way and could decrease the expression levels of Bcl-2 protein. Conclusion The h TERT ASODN can induce apoptosis of Ishikawa cells,inhibit tumor cell proliferation,and its action mechanism may be correlated to decreasing the expression levels of Bcl-2 protein.
出处 《河北医药》 CAS 2016年第9期1306-1308,共3页 Hebei Medical Journal
关键词 子宫内膜肿瘤 人端粒酶逆转录酶 反义寡聚脱氧核苷酸 BCL-2 endometrial carcinoma human telomerase reverse transcriptase antisense oligodeoxynucleotide Bcl-2
  • 相关文献

参考文献15

  • 1Lehner R,Enomoto T,Mc Gregor JA,et al.Quantitative analysis of telomerase h TERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.Gynecol Oncol,2002,84:120-125.
  • 2石绍兰,高宝莲.子宫内膜癌中Bcl-2、PTEN表达的研究[J].中国妇幼保健,2010,25(12):1632-1634. 被引量:3
  • 3Ebina Y,Yamada H,Fujino T,et al.Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma.Int J Cancer,1999,84:529-532.
  • 4Elkak AE,Meligonis G,Salhab M,et al.h TERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer.J Carcinog,2005,4:17.
  • 5杨艳,滕银成.端粒酶逆转录酶与子宫内膜癌的研究进展[J].现代妇产科进展,2011,20(1):58-60. 被引量:4
  • 6Dong H,Xiang HB,Ye DW,et al.Inhibitory effects of intrathecal p38βantisense oligonucleotide on bone cancer pain in rats.Int J Clin Exp Pathol,2014,7:7690-7698.
  • 7肖桂芝,田苗,田红,沈雪砚,陈常青.FDA加快新药审批程序及突破性治疗药物分析[J].现代药物与临床,2014,29(5):447-454. 被引量:3
  • 8Chen XJ,Zheng W,Chen LL,et al.Telomerase antisense inhibition for the proliferation of endometrial cancer in vitro and in vivo.Int J Gynecol Cancer,2006,16:1987-1993.
  • 9文华清,耿源源,胡红文,王海涛,尹伟,罗应彪.Bcl-2和Ki-67对子宫内膜病变价值的探讨[J].临床肿瘤学杂志,2009,14(7):614-618. 被引量:7
  • 10Dorjgochoo T,Xiang YB,Long J,et al.Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrialcancer risk in a Chinese population.PLo S One,2013,8:e60915.

二级参考文献107

  • 1张洁莉,孙昭,霍真,罗玉凤,马水清,王德田,曹金伶,杨缇,崔全才,白春梅.头颈部鳞癌人乳头状瘤病毒16/18感染状态与Ki-67、P53表达的关系[J].中国医学科学院学报,2010,32(4):429-432. 被引量:13
  • 2赵敬.hTERT-RNAi表达载体抑制子宫内膜癌细胞生长研究[J].天津医科大学学报,2006,12(2):214-216. 被引量:3
  • 3杨全会,许荣焜.细胞凋亡与肿瘤[J].生理科学进展,2006,37(4):373-378. 被引量:21
  • 4牛兆山,纪祥瑞.子宫内膜腺癌组织Ki-67蛋白和caspase-3表达及意义[J].齐鲁医学杂志,2007,22(3):209-211. 被引量:8
  • 5陈兴,郑锡铭,张乃哲,等.人心肌线粒体肌酸激酶的抗血清制备[J].中国学术期刊文摘,1996,2(2):119-120.
  • 6[1]Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer, 1983,31 ( 1 ) : 13 ~ 20.
  • 7[2]Oltrai Zn, Melliman CL, Korsmeyer SJ, et al. bcl-2 heterodi merizes in vivo with a consered homdog, bax, that accelerates propramed cell death. Cell, 1993,74(4):609~19.
  • 8[4]Nicolay K, Rojo M, Wallimann T, et al. The role of contact sites between inner and outer mito chondrial membrane inner and outer mito chondrial membrane in energy transfer. Biochem Biophys Acta, 1990,1018(2~3) :229~33.
  • 9Okuda T, Sekizawa A, Purwosunu Y, et al. Genetics of en- dometrial cancers [ J ]. Obstet Gynecol Int, 2010,2010 : 984013.
  • 10Bansal N,Yendluri V, Wenham RM. The molecular biolo- gy of endometrial cancers and the implications for patho- genesis, classification, and targeted therapies [J]. Cancer Control, 2009,16 : 8 - 13.

共引文献33

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部